Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-04 Sale | 2020-12-08 4:01 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 5,639 | $12.5 | $70,488 | 93,041 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 4:02 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 3,561 | $11.75 | $41,842 | 93,041 (Direct) | View |
| 2020-11-06 Sale | 2020-11-10 4:10 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 2,797 | $11.14 | $31,161 | 93,041 (Direct) | View |
| 2020-10-08 Sale | 2020-10-13 4:03 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 22,714 | $10.5 | $238,497 | 95,838 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 4:01 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 575 | $10.14 | $5,831 | 118,552 (Direct) | View |
| 2020-05-11 Sale | 2020-05-13 5:20 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 1,153 | $10.35 | $11,934 | 118,147 (Direct) | View |
| 2020-02-21 Sale | 2020-02-25 4:36 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 3,900 | $11.63 | $45,357 | 83,127 (Direct) | View |
| 2019-11-08 Sale | 2019-11-12 6:26 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 987 | $11 | $10,857 | 78,337 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-20 4:44 pm | N/A 2031-02-15 | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 111,430 | $0 | 111,430 (Direct) | View |
| 2024-02-10 Exercise | 2024-02-13 5:16 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 5,333 | $0 | 10,040 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-13 5:16 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 2,985 | $12.82 | 10,040 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 4:52 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 5,334 | $0 | 13,025 (Direct) | View |
| 2023-02-27 Tax Withholding | 2023-03-01 4:52 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 2,975 | $10.36 | 13,025 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:25 pm | N/A 2030-02-15 | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 9:09 pm | N/A 2029-02-09 | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 106,500 | $0 | 106,500 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-02 7:58 pm | N/A 2028-02-29 | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 350,000 | $0 | 350,000 (Direct) | View |
Ownership | 2021-03-02 7:55 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | MacDonald Kelly SVP and CFO | 0 | $0 | 0 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-08 4:01 pm | N/A 2026-03-01 | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 5,639 | $0 | 93,041 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-08 4:01 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 5,639 | $9.12 | 93,041 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 4:02 pm | N/A 2025-10-01 | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 3,561 | $0 | 93,041 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 4:02 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 3,561 | $9.31 | 93,041 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 4:28 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 36,173 | $0 | 119,300 (Direct) | View |
| 2019-12-16 Option Award | 2019-12-18 4:36 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | MacDonald Kelly Chief Accounting Officer | 8,230 | $0 | 86,567 (Direct) | View |